Dr. Beth N. McLellan, MD

Dr. McLellan practices at Montefiore Medical Center in Bronx, New York.

Dr. McLellan's NPI, 1356512412, was assigned on March 17, 2008. Dr. McLellan graduated from Wayne State University School of Medicine in 2007. Dr. McLellan holds New York license 260468-1.

Dr. McLellan's primary practice is Montefiore Medical Center, at 1250 Waters Pl, Bronx, NY 10461 in Bronx County. The practice phone is (718) 920-2966.

Dr. McLellan's primary practice is Montefiore Medical Center in Bronx, New York. Dr. McLellan is also affiliated with Montefiore Einstein Hospital-Moses Campus. The medical group on file is Montefiore Einstein Faculty Practice Group. Dmand AI also links Dr. McLellan to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. McLellan practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. McLellan's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. McLellan is licensed in New York.

CMS data shows 412 Medicare services from Dr. McLellan across 7 procedure codes in 2024, for 219 Medicare patients. Medicare paid $31,138 for them.

CMS counts 219 Medicare patients who saw Dr. McLellan in 2024. The largest group is 65 to 74, with 84 patients. 75% of them have high blood pressure, and 68% have high cholesterol. 48% are also on Medicaid. Their average risk score is 1.97, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. McLellan's median patient age at 60, with 59% women.

In 2024, Dr. McLellan wrote 1,843 Medicare Part D claims for 446 patients. 83% of them were for generic drugs. CMS names the drug for 1,593 of them, across 30 drugs with 11 or more claims each, at $940,592 in total drug cost. In 2023, CMS named 1,080 claims across 26 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. McLellan for performance year 2024, reported as part of a group. CMS lists Dr. McLellan as offering telehealth. CMS counts 55 procedures of removal of skin lesions by Dr. McLellan, more than 72% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 96 papers to Dr. McLellan, published from 2011 to 2025. 2020 was the busiest year, with 11. The most frequent topics are Skin Neoplasms, Antineoplastic Agents and Breast Neoplasms. Dr. McLellan has published most often in J Am Acad Dermatol. Dr. McLellan's most frequent co-authors are Roya Nazarian, Mathew Birnbaum, MD and Yevgeniy Balagula, MD.

Dmand AI links Dr. McLellan to 1 clinical trial. 1 is still active or recruiting. Open Payments lists research payments to Dr. McLellan that name 1 trial.

CMS Open Payments shows 15 general payments to Dr. McLellan from 4 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 84% of the total. Janssen Pharmaceuticals, Inc paid the most, $9,097. It also lists 26 research payments totaling $51,033 from 2020 to 2022, naming 1 clinical trial.

Dr. McLellan graduated from Wayne State University School of Medicine in 2007.